Skip to content

Radiomics Based Prediction of Microvascular Invasion in HCC

Radiomics Based Prediction of Microvascular Invasion in HCC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016165
Enrollment
Unknown
Registered
2018-05-16
Start date
2018-05-20
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Gold Standard:pathological examination or clinical outcomes
based&#32
prediction&#32
model

Sponsors

Zhuhai People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) HCC confirmed by pathologically or clinically; 2) computed tomography (CT) recorded at diagnoses; 3) patients initially treated by standard therapies recommended by guidelines such as liver resection, transarterial chemoembolization or ablation; 4) MaVI confirmed by CT or MRI, or death occurred, or without disease progression (PD) confirmed for at least 3 years.

Exclusion criteria

Exclusion criteria: 1) initially treated by treatments other than standard therapies; 2) irregular follow-up before MaVI or death.

Design outcomes

Primary

MeasureTime frame
Macrovascular invasion;

Secondary

MeasureTime frame
Progression-free Survival;

Countries

China

Contacts

Public ContactLigon Lu

Zhuhai People's Hospital

llg0902@sina.com+86 13802423169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026